EMERALD HEALTH SCIENCES INC. sold 2.4% of their position (3M shares) of SKYE BIOSCIENCE, INC. on the open market
Open‑market sale worth $300.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/11/2020ACC: 0001640334-20-002029
10% Owner
Since Nov 2018
-3M
Net shares
Net seller
$300.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3M
Price / share
$0.10
Trade value
$300K
% of position
2.4%
—
126.49M→123.49M
Total
Net shares
−3M
Net value
-$300K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | S · Sale | −3M | $0.10 | $300K | 2.4% | 126.49M | 123.49M |
| Total | −3M | -$300K | ||||||
Derivative Transactions0
No derivative transactions reported